Session 3: From molecular addiction to therapeutic strategy in NSCLC - Panel discussion

Jacques Cadranel (France), Jan Van Meerbeeck (Belgium), David Planchard (France)

Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Number: 12
Disease area: Thoracic oncology

Webcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jacques Cadranel (France), Jan Van Meerbeeck (Belgium), David Planchard (France). Session 3: From molecular addiction to therapeutic strategy in NSCLC - Panel discussion. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Session 2: From molecular target to molecular resistance in NSCLC - Panel discussion
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019

Session 1: From molecular alterations to cancer immunity in NSCLC - Panel discussion
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019

Session 5: From PD1/PD-L1 monotherapy in selected patients to PD1/PD-L1 combo for all NSCLC - Panel discussion
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019

Panel discussion: Improving the pathway of lung cancer patients, can we do it better?
Source: ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better?
Year: 2021


Formulating recommendations and identifying areas of future research - Panel discussion and protocol
Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)
Year: 2009

Early-Career delegates session - Panel discussion
Source: ERS Lung Science Conference 2021
Year: 2021

Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Session 1: The meaning of the words - General discussion
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021

New treatment concepts in stage IV NSCLC: personalized multidisciplinary approaches
Source: Virtual Congress 2021 – Hot topics in thoracic oncology
Year: 2021


Panel discussion: identify concrete areas/topics where collaboration at EU-level is necessary.
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013

Development of a pulmonary nodule service & clinical pathway: A pragmatic approach addressing an unmet need
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016